Cargando…

The purity identification and radiolabeling of α-mangostin with technetium-99m

Alpha-mangostin (AM) is a natural compound that has the greatest activity in breast cancer. Radiolabeling AM with technetium-99 m (Tc-99m) has a function as breast cancer radiotracer. This study is aimed to identify the purity of Tc-99m-labeled AM. The identification method was conducted by a valida...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muchtaridi, Muchtaridi, Setyawati, Luthfi Utami, Islamiaty, Risda Rahmi, Lie, Kevin Reinard, Nurhidayah, Wiwit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034178/ https://www.ncbi.nlm.nih.gov/pubmed/32154152 http://dx.doi.org/10.4103/japtr.JAPTR_94_19

Ejemplares similares

General toxicity studies of alpha mangostin from Garcinia mangostana: A systematic review
por: Setyawati, Luthfi Utami, et al.
Publicado: (2023)

Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents
por: Nurhidayah, Wiwit, et al.
Publicado: (2022)

Radiosynthesis, Stability, Lipophilicity, and Cellular Uptake Evaluations of [(131)I]Iodine-α-Mangostin for Breast Cancer Diagnosis and Therapy
por: Nurhidayah, Wiwit, et al.
Publicado: (2023)

Nanoparticle Drug Delivery Systems for α-Mangostin
por: Wathoni, Nasrul, et al.
Publicado: (2020)

Nanoformulations of α-Mangostin for Cancer Drug Delivery System
por: Meylina, Lisna, et al.
Publicado: (2021)

Synthesis of nano-α mangostin based on chitosan and Eudragit S 100
por: Herdiana, Yedi, et al.
Publicado: (2020)

α-Mangostin Nanoparticles Cytotoxicity and Cell Death Modalities in Breast Cancer Cell Lines
por: Herdiana, Yedi, et al.
Publicado: (2021)

Cytotoxicity Enhancement in MCF-7 Breast Cancer Cells with Depolymerized Chitosan Delivery of α-Mangostin
por: Herdiana, Yedi, et al.
Publicado: (2022)

Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells
por: Herdiana, Yedi, et al.
Publicado: (2023)

Encapsulation mechanism of α-mangostin by β-cyclodextrin: Methods of molecular docking and molecular dynamics
por: Triwahyuningtyas, Dian, et al.
Publicado: (2021)

α-Mangostin/γ-Cyclodextrin Inclusion Complex: Formation and Thermodynamic Study
por: Suharyani, Ine, et al.
Publicado: (2021)

Enhancement of α-Mangostin Wound Healing Ability by Complexation with 2-Hydroxypropyl-β-Cyclodextrin in Hydrogel Formulation
por: Wathoni, Nasrul, et al.
Publicado: (2020)

The interaction of alpha-mangostin and its derivatives against main protease enzyme in COVID-19 using in silico methods
por: Hidayat, Syahrul, et al.
Publicado: (2021)

[(99m)Tc]Technetium-Labeled Niosomes: Radiolabeling, Quality Control, and In Vitro Evaluation
por: Ekinci, Meliha, et al.
Publicado: (2023)

The Impact of Water-Soluble Chitosan on the Inhibition of Crystal Nucleation of Alpha-Mangostin from Supersaturated Solutions
por: Budiman, Arif, et al.
Publicado: (2022)

Hyaluronic Acid-Coated Chitosan Nanoparticles as an Active Targeted Carrier of Alpha Mangostin for Breast Cancer Cells
por: Meylina, Lisna, et al.
Publicado: (2023)

Formulation and Characterization of α-Mangostin in Chitosan Nanoparticles Coated by Sodium Alginate, Sodium Silicate, and Polyethylene Glycol
por: Wathoni, Nasrul, et al.
Publicado: (2019)

Chitosan/Alginate Polymeric Nanoparticle-Loaded α-Mangostin: Characterization, Cytotoxicity, and In Vivo Evaluation against Breast Cancer Cells
por: Muchtaridi, Muchtaridi, et al.
Publicado: (2023)

Molecular dynamics simulation of Fe-NO(2) At-alpha mangostin as radiopharmaceutical model for detection of fatty acid synthase in cancer
por: Rosilawati, N. Elly, et al.
Publicado: (2021)

Effect of Drug–Polymer Interaction in Amorphous Solid Dispersion on the Physical Stability and Dissolution of Drugs: The Case of Alpha-Mangostin
por: Budiman, Arif, et al.
Publicado: (2023)

The Potential Cytotoxic Activity Enhancement of α-Mangostin in Chitosan-Kappa Carrageenan-Loaded Nanoparticle against MCF-7 Cell Line
por: Wathoni, Nasrul, et al.
Publicado: (2021)

Biodistribution of Mesoporous Carbon Nanoparticles via Technetium-99m Radiolabelling after Oral Administration to Mice
por: Mamai, Maria, et al.
Publicado: (2021)

Inhibition of Crystal Nucleation and Growth in Aqueous Drug Solutions: Impact of Different Polymers on the Supersaturation Profiles of Amorphous Drugs—The Case of Alpha-Mangostin
por: Budiman, Arif, et al.
Publicado: (2022)

Platelet-12 lipoxygenase targeting via a newly synthesized curcumin derivative radiolabeled with technetium-99m
por: Al-Wabli, Reem Ibrahim, et al.
Publicado: (2016)

Technetium-99m chelator-free radiolabeling of specific glutamine tumor imaging nanoprobe: in vitro and in vivo evaluations
por: Ghoreishi, Seyedeh Masoumeh, et al.
Publicado: (2018)

Quality control on radiochemical purity in Technetium-99m radiopharmaceuticals labelling: three years of experience on 2280 procedures
por: Maioli, Claudio, et al.
Publicado: (2017)

Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m
por: Klingler, Maximilian, et al.
Publicado: (2019)

Diagnosis of bone infection by complementary role of technetium-99m MDP and technetium-99m hexamethylpropylene-amineoxime-leukocytes
por: Al-Zahrani, Abdullah, et al.
Publicado: (2012)

Method development, validation, and impurity measurement of β-estradiol from radiolabeled [(131)I]β-estradiol using radio-high-performance liquid chromatography for radioligand of saturation binding assay
por: Daruwati, Isti, et al.
Publicado: (2023)

Synthesis and antimicrobial evaluation of two peptide LyeTx I derivatives modified with the chelating agent HYNIC for radiolabeling with technetium-99m
por: Fuscaldi, Leonardo Lima, et al.
Publicado: (2016)

Optimising the radiolabelling properties of technetium tricarbonyl and His-tagged proteins
por: Badar, Adam, et al.
Publicado: (2014)

Technetium-99m production issues in the United Kingdom
por: Green, Christopher H.
Publicado: (2012)

Estrogen receptor targeting with genistein radiolabeled Technetium-99(m) as radiotracer of breast cancer: Its optimization, characterization, and predicting stability constants by DFT calculation
por: Ramdhani, Danni, et al.
Publicado: (2023)

(99m)Technetium Sestamibi-(123)Iodine Scintigraphy Is More Accurate Than (99m)Technetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism
por: Ryhänen, Eeva M., et al.
Publicado: (2015)

TrisOxine abiotic siderophores for technetium complexation: radiolabeling and biodistribution studies
por: Leenhardt, Julien, et al.
Publicado: (2023)

Options for UK Technetium-99m Production using Accelerators
por: H.L. Owen, et al.
Publicado: (2014)

99m-Technetium Sestamibi Uptake in a Gastric Schwannoma
por: Shawgi, Mohamed, et al.
Publicado: (2018)

Innovative Target for Production of Technetium-99m by Biomedical Cyclotron
por: Skliarova, Hanna, et al.
Publicado: (2018)

Poor renal uptake of technetium-99m-DMSA and technetium-99m-MDP in a patient with Fanconi syndrome and near normal glomerular filtration rate.
por: Kim, S. E., et al.
Publicado: (1994)

Hybridised production of technetium-99m and technetium-101 with fluorine-18 on a low-energy biomedical cyclotron
por: Johnstone, Erik V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vreu2egucrf0if9ghn4tn47v29